Let's see, what does the guide to the entire universe have to say that could possibly help us in the face of a virulent virus? Two words.
This market is all about the news flow and it is not going to provide much upside opportunity until there is more clarity, even if the headlines are bad.
The Chinese people are about to learn the extent of economic distress.
The market is all about technicals now. The real buying will only come once the virus is contained or Fed goes all in, as China seems to be willing to do so at all costs.
Here's a framework for analyzing incoming information as the disease spreads across the globe.
It's clear that the market infection from the Wuhan pneumonia is only just beginning.
History shows that 'scary sell-offs' often turn into bounce-backs, so here's some advice for uncertain times like this.
There are no prior examples when a sharp drop comes right after making new all-time highs while also extremely overbought.
You have to invest with your eyes wide open -- especially to the mirage of stock-based exchange-traded funds.
The market ended up suffering some very classic corrective action on Monday, and now's no time to buy.
The answer to that question depends on several factors, so let's break them down.
While it might be tempting to buy any dip, the coronavirus' quick spread, recent downgrades, softness in services and other factors should give pause.
I would consider any entry a trade, and not an investment.
The widening coronavirus outbreak, the contentious 2020 presidential race and mediocre earnings growth prospects all pose threats to equities.
India is Asia's least-affected economy in terms of the coronavirus outbreak. It should benefit despite a low-level 'trade skirmish.'
Any modest intraday dip is probably a buying opportunity.
Here are a number of things that I'm watching now.
Did you ever think that could be allowed? That our government let that happen? No one seemed to think about it until now. The answer, like the coronavirus, is we knew.
Beijing is allowing banks to relax lending standards, which could mask many nonperforming loans while problem borrowing rises as high as 13.3% of Chinese debt.
While some 'pruning' can be necessary, Thursday was a strange day to get clipped.
The world's most levered balance sheet belongs not to a company, but to a country: Japan.
The ultimate economic impact of the disease isn't clear, but what is clear is who is most at risk and where you're mostly likely to contract it.
The world's third-largest economy is likely to now be in recession, and Japanese investors have sensibly switched into defensive sectors and low-volatility stocks.
There's too much upside, not enough downside, so the selling, which should have begun, just hasn't happened.
Plenty of pundits told why they thought AAPL's big news Tuesday didn't matter, but let's peel them back. Also, have noticed there's little selling -- or buying -- of late?
The indexes simply refuse to do the logical thing and pull back, which would help bears and bulls alike.
A wide variety of tech companies are likely to see their March-quarter sales hurt by the coronavirus outbreak's impact on Chinese demand and/or manufacturing.
The human cost of the virus is real, so don't overlook that, but also know the companies who are in a position to benefit.
Two trades I'm making (and one on my radar) as a I stay focused on the price action.
A.O. Smith is a high-growth dividend stock.